News

Fierce Pharma44m
Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid
With sales of its lone product in a precipitous decline in the United States, Amarin has turned to an experienced local ...
Fierce Pharma1h
Cassidy, key in RFK Jr.'s HHS confirmation, calls for deferral of CDC's vaccine meeting
La., has come out critical of Robert F. | Sen. Bill Cassidy, M.D., R-La., has come out critical of Robert F. Kennedy Jr.’s ...
Fierce Pharma1h
London calling: The Bloc expands into UK with new office, executive hires
The new U.K. office will join more than a dozen others across the pond, including in Paris, Milan, Amsterdam and more. Elsewhere, The Bloc holds several offices in the Asia-Pacific region and both ...
Fierce Pharma2h
Craig Romanok follows Omnicom-to-Publicis path, taking up chief commercial officer post at Digitas
Publicis Health has snapped up another Omnicom Health Group executive. | Publicis Health has snapped up another Omnicom ...
Fierce Pharma4h
AZ, Daiichi's Datroway scores its 2nd FDA approval—this time in lung cancer subset
The FDA has blessed AstraZeneca and Daiichi Sankyo’s Datroway to treat patients with locally advanced or metastatic epidermal ...
Fierce Pharma20h
UK lays out strategy to become a top 3 life sciences economy by 2035
For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the ...
Fierce Pharma22h
FDA's acting CDER head Jacqueline Corrigan-Curay heads for the exit amid period of heavy turnover: reports
In the wake of Marks' exit, FDA commissioner Marty Makary, M.D., named Vinay Prasad, M.D., to head up CBER. In addition to that title, Prasad recently added the title of "chief medical and science ...